Clinical Trials Browser

Phase EARLY_PHASE1 × Unresectable or Metastatic Advanced Solid Tumors × Clear all

NCT06026605 2025-01-16

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Unresectable or Metastatic Advanced Solid Tumors